辅助玻璃体视网膜手术的药物研究进展

玻璃体切割术的主要目的是切除病变玻璃体和解除玻璃体对视网膜的牵拉。难度在于玻璃体与视网膜之间存在紧密粘连或有玻璃体后脱离。药物辅助的玻璃体视网膜手术是指先于玻璃体切割操作即应用药物促进玻璃体的液化或使玻璃体内纤维增生膜溶解，以解除玻璃体对视网膜的牵引，从而提高手术效率和安全性。就玻璃体视网膜手术辅助药物的研究进展进行综述。

Current progression in the research on assisted drug of vitrectomy

The attempt of vitrectomy is to remove the lesion of vitreous body and relieve vitreous traction to retina.Whether the vitrectomy is successful or not depend on if exist a close adhesion between vitreous body and retina or a posterior vitreous detachment (PVD).The drug assisted vitrectomy is a new technique.These drugs can help surgeon to form PVD during surgery safely and effectively.The drug is utilized prior to vitreoretinal operation to promote the colliquate of vitreous body or dissolve of fibroplasia membrane of the vitreous body in order to release the traction between the posterior cortex of vitreous body and the inner limiting membrane of retina.The research advance in relevant drugs is reviewed in this article.